Moshe Arkin 13D and 13G filings for UroGen Pharma Ltd.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-22 09:23 am Unchanged | 2023-07-28 | 13D | UroGen Pharma Ltd. URGN | Moshe Arkin | 1,369,315 4.440% | 0 (Unchanged) | Filing |